Maleszewski JJ, Basso C, Bois MC et al (2022) The 2021 WHO classification of tumors of the heart. J Thorac Oncol 17:510–518. https://doi.org/10.1016/j.jtho.2021.10.021

Article  PubMed  Google Scholar 

Tyebally S, Chen D, Bhattacharyya S et al (2020) Cardiac tumors: JACC CardioOncology state-of-the-art review. JACC Cardiooncol 2:293–311. https://doi.org/10.1016/j.jaccao.2020.05.009

Article  PubMed  PubMed Central  Google Scholar 

Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol 10:1240–1242. https://doi.org/10.1097/JTO.0000000000000663

Article  PubMed  Google Scholar 

Burke AP, Virmani R (1993) Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol 100:671–680. https://doi.org/10.1093/ajcp/100.6.671

Article  PubMed  Google Scholar 

Dell’Aquila M, Carbone A, Pennacchia I, Stigliano E, Oliva A, Arena V (2020) Sudden death by massive systemic embolism from cardiac myxoma Role of the clinical autopsy and review of literature. Cardiovasc Pathol 49:107244. https://doi.org/10.1016/j.carpath.2020.107244

Article  PubMed  Google Scholar 

Kalçık M, Bayam E, Güner A et al (2019) Evaluation of the potential predictors of embolism in patients with left atrial myxoma. Echocardiography 36:837–843. https://doi.org/10.1111/echo.14331

Article  PubMed  Google Scholar 

Pinede L, Duhaut P, Loire R (2001) Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Med (Baltim) 80:159–172. https://doi.org/10.1097/00005792-200105000-00002

Article  Google Scholar 

Burke A, Jeudy J Jr, Virmani R (2008) Cardiac tumours: an update: Cardiac tumours. Heart 94:117–123. https://doi.org/10.1136/hrt.2005.078576

Article  PubMed  Google Scholar 

He DK, Zhang YF, Liang Y et al (2015) Risk factors for embolism in cardiac myxoma: a retrospective analysis. Med Sci Monit 21:1146–1154. https://doi.org/10.12659/MSM.893855

Acebo E, Val-Bernal JF, Gómez-Román JJ, Revuelta JM (2003) Clinicopathologic study and DNA analysis of 37 cardiac myxomas: a 28-year experience. Chest 123:1379–1385. https://doi.org/10.1378/chest.123.5.1379

Article  PubMed  Google Scholar 

Liu Y, Wang J, Guo L, Ping L (2020) Risk factors of embolism for the cardiac myxoma patients: a systematic review and metanalysis. BMC Cardiovasc Disord 20:348. https://doi.org/10.1186/s12872-020-01631-w

Article  PubMed  PubMed Central  Google Scholar 

Ma G, Wang D, He Y, Zhang R, Zhou Y, Ying K (2019) Pulmonary embolism as the initial manifestation of right atrial myxoma: a case report and review of the literature. Med (Baltim) 98:e18386. https://doi.org/10.1097/MD.0000000000018386

Article  Google Scholar 

Tulin R, Geana RC, Robu M et al (2022) Predictors of late mortality in patients with surgically resected cardiac myxomas: a single-center experience. Cureus 14:e20866. https://doi.org/10.7759/cureus.20866

Article  PubMed  PubMed Central  Google Scholar 

Lamba G, Frishman WH (2012) Cardiac and pericardial tumors. Cardiol Rev 20:237–252. https://doi.org/10.7759/cureus.20866

Article  PubMed  Google Scholar 

Zheng JJ, Geng XG, Wang HC, Yan Y, Wang HY (2013) Clinical and histopathological analysis of 66 cases with cardiac myxoma. Asian Pac J Cancer Prev 14:1743–1746. https://doi.org/10.7314/apjcp.2013.14.3.1743

Article  PubMed  Google Scholar 

Karpathiou G, Dumollard JM, Camy F et al (2021) Senescence, immune microenvironment, and vascularization in cardiac myxomas. Cardiovasc Pathol 52:107335. https://doi.org/10.1016/j.carpath.2021.107335

Article  PubMed  Google Scholar 

Carney JA (1985) Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol 9:53–55. https://doi.org/10.1097/00000478-198501000-00009

Article  PubMed  Google Scholar 

Roque A, Kimbrough T, Traner C et al (2019) Somatic PRKAR1A mutation in sporadic atrial myxoma with cerebral parenchymal metastases: a case report. J Med Case Rep 13:389. https://doi.org/10.1186/s13256-019-2317-z

Article  PubMed  PubMed Central  Google Scholar 

Maleszewski JJ, Larsen BT, Kip NS et al (2014) PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors. Am J Surg Pathol 38:1079–1087. https://doi.org/10.1097/PAS.0000000000000202

Article  PubMed  Google Scholar 

Orlandi A, Ciucci A, Ferlosio A, Genta R, Spagnoli LG, Gabbiani G (2006) Cardiac myxoma cells exhibit embryonic endocardial stem cell features. J Pathol 209:231–239. https://doi.org/10.1002/path.1959

Article  PubMed  Google Scholar 

Kodama H, Hirotani T, Suzuki Y, Ogawa S, Yamazaki K (2002) Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors. Am J Pathol 161:381–389. https://doi.org/10.1016/S0002-9440(10)64193-4

Article  PubMed  PubMed Central  Google Scholar 

Di Vito A, Mignogna C, Donato G (2015) The mysterious pathways of cardiac myxomas: a review of histogenesis, pathogenesis and pathology. Histopathology 66:321–332. https://doi.org/10.1111/his.12531

Article  PubMed  Google Scholar 

Orlandi A, Ciucci A, Ferlosio A, Pellegrino A, Chiariello L, Spagnoli LG (2005) Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas. Am J Pathol 166:1619–1628. https://doi.org/10.1016/S0002-9440(10)62472-8

Article  PubMed  PubMed Central  Google Scholar 

Gošev I, Paić F, Durić Z et al (2013) Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. Int J Cardiol 164:7–20. https://doi.org/10.1016/j.ijcard.2011.12.052

Article  PubMed  Google Scholar